We are live on
!
Find out more
HP
HealthInvest Partners Portfolio holdings
AUM
$372M
1-Year Est. Return
59.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.77%
1 Year Est. Return
+59.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$227M
AUM Growth
+$15.7M
(+7.4%)
Cap. Flow
+$1.83M
Cap. Flow
% of AUM
0.81%
Top 10 Holdings %
Top 10 Hldgs %
59.15%
Holding
41
New
5
Increased
10
Reduced
19
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$8.49M |
| 2 |
Gilead Sciences
GILD
|
+$7.95M |
| 3 |
ONC
BeOne Medicines Ltd
ONC
|
+$3.33M |
| 4 |
Krystal Biotech
KRYS
|
+$2.4M |
| 5 |
iRhythm Holdings
IRTC
|
+$2.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.94M |
| 2 |
UnitedHealth
UNH
|
+$4.82M |
| 3 |
FOLD
Amicus Therapeutics
FOLD
|
+$3.08M |
| 4 |
Boston Scientific
BSX
|
+$2.21M |
| 5 |
Eli Lilly
LLY
|
+$2.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
NewAmsterdam Pharma
NAMS
$3.3B
| $2.21M | 0.97% |
107,783
-31,200
| -22% | -$694K |
|
|
VRNA
27
DELISTED
Verona Pharma
VRNA
| $2.2M | 0.97% |
+34,690
| New | +$2.07M |
|
|
28
iRhythm Holdings
IRTC
$4.02B
| $2.15M | 0.95% |
+20,547
| New | +$2.18M |
|
29
Summit Therapeutics
SMMT
$12.1B
| $2.03M | 0.89% |
105,077
+3,900
| +4% | +$78.2K |
|
30
Revolution Medicines
RVMD
$44.1B
| $1.94M | 0.86% |
54,961
-7,200
| -12% | -$292K |
|
|
BCAX
31
Bicara Therapeutics
BCAX
$1.56B
| $1.56M | 0.69% |
+119,833
| New | +$1.59M |
|
|
MRUS
32
DELISTED
Merus
MRUS
| $1.49M | 0.66% |
35,292
-27,229
| -44% | -$1.19M |
|
33
Janux Therapeutics
JANX
$1.01B
| $1.26M | 0.56% |
46,808
+7,235
| +18% | +$273K |
|
|
MREO
34
Mereo BioPharma
MREO
$48.8M
| $878K | 0.39% |
390,000
| – | – |
|
|
AUTL
35
Autolus Therapeutics
AUTL
$620M
| $743K | 0.33% |
479,644
| – | – |
|
36
Corbus Pharmaceuticals
CRBP
$184M
| $522K | 0.23% |
98,304
| – | – |
|
37
Cabaletta Bio
CABA
$455M
| $253K | 0.11% |
182,354
-65,100
| -26% | -$139K |
|
|
FOLD
38
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-326,840
| Closed | -$3.08M |
|
|
MRSN
39
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-21,545
| Closed | -$765K |
|
40
Pharvaris
PHVS
$2.41B
| – | – |
-34,328
| Closed | -$653K |
|
|
ITCI
41
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-71,138
| Closed | -$5.94M |
|
Similar funds
KP
TCM
SAAM
PC
GIP
PC
DPCM
OCMH
HealthInvest Partners's Q1 2025 Portfolio in Review
As of Q1 2025, HealthInvest Partners held 41 positions worth $227M, up 7.4% from $211M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
HealthInvest Partners's Q1 2025 filing shows 5 new, 10 increased, 19 reduced and 4 closed positions. Its largest new stake was Intuitive Surgical: 15,345 shares worth $7.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $5.94M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- HealthInvest Partners's largest Q1 2025 buy was Intuitive Surgical: 15,345 shares worth $7.6M.
- HealthInvest Partners added most to BeOne Medicines Ltd in Q1 2025, an estimated $3.33M increase.
- HealthInvest Partners's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $4.82M.
- HealthInvest Partners fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $5.94M.
- HealthInvest Partners's ten largest holdings make up 59% of its $227M portfolio in Q1 2025.
- HealthInvest Partners opened 5 new positions and closed 4 in Q1 2025.
- HealthInvest Partners's portfolio value rose 7.4% quarter-over-quarter to $227M.
Based on HealthInvest Partners's 13F filing for Q1 2025, filed 5 May 2025.